274 related articles for article (PubMed ID: 22791270)
1. Radiologic analysis of the effect of tocilizumab on hands and large joints in children with systemic juvenile idiopathic arthritis.
Inaba Y; Ozawa R; Aoki C; Imagawa T; Mori M; Hara R; Miyamae T; Saito T; Yokota S
Mod Rheumatol; 2013 Jul; 23(4):667-73. PubMed ID: 22791270
[TBL] [Abstract][Full Text] [Related]
2. Discrepancy between clinical and radiological responses to tocilizumab treatment in patients with systemic-onset juvenile idiopathic arthritis.
Aoki C; Inaba Y; Choe H; Kaneko U; Hara R; Miyamae T; Imagawa T; Mori M; Oba MS; Yokota S; Saito T
J Rheumatol; 2014 Jun; 41(6):1171-7. PubMed ID: 24786929
[TBL] [Abstract][Full Text] [Related]
3. Radiographic improvement of damaged large joints in children with systemic juvenile idiopathic arthritis following tocilizumab treatment.
Inaba Y; Ozawa R; Imagawa T; Mori M; Hara Y; Miyamae T; Aoki C; Saito T; Yokota S
Ann Rheum Dis; 2011 Sep; 70(9):1693-5. PubMed ID: 21402562
[No Abstract] [Full Text] [Related]
4. Tocilizumab may slow radiographic progression in patients with systemic or polyarticular-course juvenile idiopathic arthritis: post hoc radiographic analysis from two randomized controlled trials.
Malattia C; Ruperto N; Pederzoli S; Palmisani E; Pistorio A; Wouters C; Dolezalova P; Flato B; Garay S; Giancane G; Wells C; Douglass W; Brunner HI; De Benedetti F; Ravelli A;
Arthritis Res Ther; 2020 Sep; 22(1):211. PubMed ID: 32912276
[TBL] [Abstract][Full Text] [Related]
5. Radiologic features in juvenile idiopathic arthritis: a first step in the development of a standardized assessment method.
van Rossum MA; Zwinderman AH; Boers M; Dijkmans BA; van Soesbergen RM; Fiselier TJ; Franssen MJ; ten Cate R; van Suijlekom-Smit LW; Wulffraat NM; Kuis W; van Luijk WH; Oostveen JC; Dijkstra PF;
Arthritis Rheum; 2003 Feb; 48(2):507-15. PubMed ID: 12571861
[TBL] [Abstract][Full Text] [Related]
6. Experience with etanercept, tocilizumab and interleukin-1 inhibitors in systemic onset juvenile idiopathic arthritis patients from the BIKER registry.
Horneff G; Schulz AC; Klotsche J; Hospach A; Minden K; Foeldvari I; Trauzeddel R; Ganser G; Weller-Heinemann F; Haas JP
Arthritis Res Ther; 2017 Nov; 19(1):256. PubMed ID: 29166924
[TBL] [Abstract][Full Text] [Related]
7. Open label phase II trial of single, ascending doses of MRA in Caucasian children with severe systemic juvenile idiopathic arthritis: proof of principle of the efficacy of IL-6 receptor blockade in this type of arthritis and demonstration of prolonged clinical improvement.
Woo P; Wilkinson N; Prieur AM; Southwood T; Leone V; Livermore P; Wythe H; Thomson D; Kishimoto T
Arthritis Res Ther; 2005; 7(6):R1281-8. PubMed ID: 16277681
[TBL] [Abstract][Full Text] [Related]
8. Frequency of radiographic damage and progression in individual joints in children with juvenile idiopathic arthritis.
Giancane G; Pederzoli S; Norambuena X; Ioseliani M; Sato J; Gallo MC; Negro G; Pistorio A; Ruperto N; Martini A; Ravelli A
Arthritis Care Res (Hoboken); 2014 Jan; 66(1):27-33. PubMed ID: 23983211
[TBL] [Abstract][Full Text] [Related]
9. [Knee joint synovectomy in treatment of juvenile idiopathic arthritis].
Adamec O; Dungl P; Kasal T; Chomiak J
Acta Chir Orthop Traumatol Cech; 2002; 69(6):350-6. PubMed ID: 12587496
[TBL] [Abstract][Full Text] [Related]
10. Effect of tocilizumab on growth impairment in systemic juvenile idiopathic arthritis with long-term corticosteroid therapy.
Miyamae T; Yokoya S; Yamanaka H; Yokota S
Mod Rheumatol; 2014 Jul; 24(4):567-71. PubMed ID: 24252004
[TBL] [Abstract][Full Text] [Related]
11. Macrophage Activation Syndrome in Patients with Systemic Juvenile Idiopathic Arthritis under Treatment with Tocilizumab.
Yokota S; Itoh Y; Morio T; Sumitomo N; Daimaru K; Minota S
J Rheumatol; 2015 Apr; 42(4):712-22. PubMed ID: 25684767
[TBL] [Abstract][Full Text] [Related]
12. Comparisons of the outcomes between early and late tocilizumab treatment in systemic juvenile idiopathic arthritis.
Pacharapakornpong T; Vallibhakara SA; Lerkvaleekul B; Vilaiyuk S
Rheumatol Int; 2017 Feb; 37(2):251-255. PubMed ID: 27798725
[TBL] [Abstract][Full Text] [Related]
13. Power Doppler ultrasonography is useful for assessing disease activity and predicting joint destruction in rheumatoid arthritis patients receiving tocilizumab--preliminary data.
Hama M; Uehara T; Takase K; Ihata A; Ueda A; Takeno M; Shizukuishi K; Tateishi U; Ishigatsubo Y
Rheumatol Int; 2012 May; 32(5):1327-33. PubMed ID: 21293859
[TBL] [Abstract][Full Text] [Related]
14. Longterm safety and effectiveness of the anti-interleukin 6 receptor monoclonal antibody tocilizumab in patients with systemic juvenile idiopathic arthritis in Japan.
Yokota S; Imagawa T; Mori M; Miyamae T; Takei S; Iwata N; Umebayashi H; Murata T; Miyoshi M; Tomiita M; Nishimoto N; Kishimoto T
J Rheumatol; 2014 Apr; 41(4):759-67. PubMed ID: 24634205
[TBL] [Abstract][Full Text] [Related]
15. Safety and response to influenza vaccine in patients with systemic-onset juvenile idiopathic arthritis receiving tocilizumab.
Shinoki T; Hara R; Kaneko U; Miyamae T; Imagawa T; Mori M; Yokota S
Mod Rheumatol; 2012 Nov; 22(6):871-6. PubMed ID: 22322589
[TBL] [Abstract][Full Text] [Related]
16. Decreased cartilage thickness in juvenile idiopathic arthritis assessed by ultrasonography.
Pradsgaard DØ; Spannow AH; Heuck C; Herlin T
J Rheumatol; 2013 Sep; 40(9):1596-603. PubMed ID: 23818714
[TBL] [Abstract][Full Text] [Related]
17. Radiologic classification of joint destruction in juvenile chronic arthritis.
Pettersson H; Rydholm U
Acta Radiol Diagn (Stockh); 1985; 26(6):719-22. PubMed ID: 4083068
[TBL] [Abstract][Full Text] [Related]
18. Analysis of disease activity, functional disability and articular damage in patients with juvenile idiopathic arthritis: a prospective outcome study.
Susic GZ; Stojanovic RM; Pejnovic NN; Damjanov NS; Soldatovic II; Jablanovic DB; Sefik Bukilica MN
Clin Exp Rheumatol; 2011; 29(2):337-44. PubMed ID: 21385554
[TBL] [Abstract][Full Text] [Related]
19. Radiographic damage in hands and wrists of patients with juvenile idiopathic arthritis after 29 years of disease duration.
Selvaag AM; Kirkhus E; Törnqvist L; Lilleby V; Aulie HA; Flatø B
Pediatr Rheumatol Online J; 2017 Apr; 15(1):20. PubMed ID: 28399930
[TBL] [Abstract][Full Text] [Related]
20. Safety of tocilizumab in the treatment of juvenile idiopathic arthritis.
Machado SH; Xavier RM
Expert Opin Drug Saf; 2017 Apr; 16(4):493-500. PubMed ID: 28277841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
